SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001822629-24-000008
Filing Date
2024-03-25
Accepted
2024-03-25 16:09:50
Documents
1
Period of Report
2024-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1711397380.html 4  
1 FORM 4 wk-form4_1711397380.xml 4 3486
  Complete submission text file 0001822629-24-000008.txt   5120
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET BAUDETTE MN 56623
Business Address
Lalwani Nikhil (Reporting) CIK: 0001822629 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 24779307